Raymond James Reiterates Outperform Rating for Knight Therapeutics (TSE:GUD) Trent Times
Raymond James restated their outperform rating on shares of Knight Therapeutics (TSE:GUD) in a research note published on Thursday, BayStreet.CA reports.
Raymond James Reiterates Outperform Rating for Knight Therapeutics (TSE:GUD) Trent Times
Raymond James restated their outperform rating on shares of Knight Therapeutics (TSE:GUD) in a research note published on Thursday, BayStreet.CA reports.